fig2
![Comparison of functional outcomes after endovascular thrombectomy in patients with and without atrial fibrillation](https://image.oaes.cc/63c49068-e1d9-49ef-acdf-9c70128b1695/4071.fig.2.jpg)
Figure 2. Distribution of 90-day modified Rankin Score by atrial fibrillation (AF) status (A) and therapeutic anticoagulation status (B) in endovascular thrombectomy patients. (B) Comparison of the AF cohort who were on therapeutic anticoagulation [warfarin/non-Vitamin K oral anticoagulant (NOAC)] with the remainder of the cohort (subtherapeutic warfarin, non-compliant with NOAC, antiplatelet therapy, or no treatment).